Citation: Ag. Taghian et P. Chastagner, Animal models: a tool for research in radiation oncology, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 26-35
Authors:
Maingon, P
Dalloz, F
Cottin, Y
Rochette, L
Citation: P. Maingon et al., Anthracyclines and radiotherapy: theoretical basis for cardiac toxicity, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 36-38
Authors:
Chastagner, P
Taghian, A
Marchal, C
Kozin, SV
Hoffstetter, S
Merlin, JL
Duprez, A
Citation: P. Chastagner et al., Effects of combined radiotherapy and topotecan on four human tumor xenografts, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 39-55
Authors:
Gregoire, V
Hittelman, WN
Milas, L
Scalliet, P
Citation: V. Gregoire et al., Radiosensitization by nucleoside analogues: biological bases and clinical prospects, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 56-72
Citation: Jf. Bosset et M. Marty, Clinical evaluation of and practical recommendations far concomitant chemoradiation, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 75-77
Citation: Jp. Gerard et al., Local control of the primary tumor: a mandatory step in curing cancer, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 78-82
Citation: J. Honnorat, Concomitant chemoradiation and malignant gliomas in adults, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 83-91
Citation: F. Mornex et al., Locally advanced non-small-cell lung cancer: the role of neoadjuvant or definitive chemoradiation, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 106-120
Citation: Jf. Morere et al., What approach should we adopt to non-small-cell lung cancer in the elderlypatient?, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 121-127
Citation: F. Mornex et B. Chauffert, Concomitant chemoradiation in the management of exocrine pancreatic and gastric adenocarcinoma, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 139-148
Citation: Jf. Bosset et P. Maingon, Adjuvant chemoradiation for rectal cancer, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 149-155
Citation: Jp. Gerard, Concomitant chemoradiation in the treatment of cancer of the anal canal, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 156-162
Citation: M. Housset et B. Dufour, Concomitant chemoradiation for invasive bladder cancer, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 163-169
Authors:
Maingon, P
Coucke, PA
Haie-Meder, C
Barillot, I
Citation: P. Maingon et al., Concomitant chemoradiation in carcinoma of the cervix, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 170-177
Citation: G. Freyer et P. Romestaing, The respective roles of radiotherapy and chemotherapy in the adjuvant treatment of breast cancer: theoretical value and feasibility of chemoradiation, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 178-190
Citation: L. Thomas et Aj. Cochran, Diagnosis and management of cutaneous malignant melanoma, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 191-213
Authors:
Lagarde, P
Kantor, G
Tawfiq, N
Salem, N
Thomas, L
Stockel, E
Bui, NB
Citation: P. Lagarde et al., Chemoradiation of soft tissue sarcomas in adults, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 214-220
Citation: Jp. Droz, Does neoadjuvant chemotherapy with curative intent have a role in treatment of early stage or locally advanced cancer?, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 232-235
Citation: E. Le Prise, Esophageal therapy on cancer: the impact of neoadjuvant operative morbidity and mortality, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 236-245